RecruitingNCT05660642
Safety of intranasal BPL-003, alone or with SSRIs, for treatment-resistant depression
About this title
Read the official source — NCT05660642This study evaluates the safety of BPL-003 for people with depression.
Medication studyAges 18–75United Kingdom
Understand this study
What is this study about?
This study evaluates the safety of BPL-003 for people with depression.
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.
- Listed locations
- Liverpool and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 10, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 72
- Sponsor
- Beckley Psytech Limited
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United Kingdom
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT05660642
- Official title
Show the full official title
An Open-Label, Phase 2a Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Liverpool · London
Interested in joining this study?
Questions about this study
What is this study about?
This study evaluates the safety of BPL-003 for people with depression.
Who is behind this study?
The study sponsor is Beckley Psytech Limited.
Does this study involve medication?
Yes. The study involves medication, including BPL-003.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
